المؤلفون: Xin Wu, Chunmei Ban, Woding Deng, Xuewei Bao, Ning Tang, Yupeng Wu, Zhixuan Deng, Jianbin Xiong, Qiangqiang Zhao

المصدر: Molecular Cancer, Vol 23, Iss 1, Pp 1-25 (2024)

مصطلحات موضوعية: Diffuse large B-cell lymphoma, PDK4, Rituximab resistance, Advanced exosome nanoparticles, Targeted therapy, Immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1476-4598

URL الوصول: https://doaj.org/article/ccdf622ccda94fb29dce04252b4e7c60

المؤلفون: Tania Salehi, Anoushka Krishnan, Ayman Al Jurdi, Paolo So, Edgar Lerma, Nasim Wiegley

المصدر: Kidney Medicine, Vol 6, Iss 4, Pp 100791- (2024)

مصطلحات موضوعية: Antidrug antibodies, B-cell depletion therapy, CD20 antigen, glomerular disease, human antichimeric antibodies, rituximab resistance, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2590059524000025; https://doaj.org/toc/2590-0595

URL الوصول: https://doaj.org/article/c05d739cc38444a795f59e1f36917219

المؤلفون: Wu, Xin, Ban, Chunmei, Deng, Woding, Bao, Xuewei, Tang, Ning, Wu, Yupeng, Deng, Zhixuan, Xiong, Jianbin, Zhao, Qiangqiang^{Aff2, Aff4, IDs12943024020570_cor9}

المصدر: Molecular Cancer. 23(1)

المؤلفون: Zhengrui Xiao, Irina Murakhovskaya

المصدر: Frontiers in Immunology, Vol 14 (2023)

مصطلحات موضوعية: ITP, immune thrombocytopenia, rituximab, rituximab refractory, rituximab resistance, novel therapies, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1215216/full; https://doaj.org/toc/1664-3224

URL الوصول: https://doaj.org/article/9c3c2fc0411042358fddca2dff079fd7

المؤلفون: Xiaowen Ge, Yiqun Du, Jianfeng Chen, Na Zhu, Jiamei Yao, Xin Zhang, Na Wang, Yujing Sun, Feng Gao, Weiguo Hu, Yingyong Hou

المصدر: Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: rituximab resistance, CD59, NF-κB, curcumin, perillyl alcohol, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.751904/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/abd6fd3dc3de40ffbae2b79c0eae1dbe

المؤلفون: Vega, Gabriel G, Franco-Cea, Luz Areli, Huerta-Yepez, Sara, Mayani, Héctor, Morrison, Sherie L, Bonavida, Benjamin, Vega, Mario I

المصدر: International Journal of Oncology. 47(5)

مصطلحات موضوعية: Lymphoma, Orphan Drug, Hematology, Cancer, Rare Diseases, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Animals, Antigens, CD20, Apoptosis, Cell Line, Tumor, Cell Proliferation, Drug Resistance, Neoplasm, Humans, Imidazoles, Interferon-alpha, Lymphoma, B-Cell, Mice, Oncogene Proteins, Fusion, Pyridines, Rituximab, p38 Mitogen-Activated Protein Kinases, lymphoma, rituximab-resistance, IFN-alpha, anti-CD20-hIFN-alpha, chemosensitivity, cytotoxicity, Oncology and Carcinogenesis, Oncology & Carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/510290wx

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bonavida, Benjamin^Aff3

المساهمون: Bonavida, Benjamin, Series editor^{Aff1, Aff2}

المصدر: Resistance to Immunotherapeutic Antibodies in Cancer : Strategies to Overcome Resistance. 2:93-124

المؤلفون: Hernandez-Ilizaliturri, Francisco J.^Aff3, Czuczman, Myron S.^Aff3

المساهمون: Bonavida, Benjamin, Series editor^{Aff1, Aff2}

المصدر: Resistance to Immunotherapeutic Antibodies in Cancer : Strategies to Overcome Resistance. 2:73-92

المؤلفون: Ada H. V. Repetto-Llamazares, Jostein Dahle, Anne Hansen Ree, Marion Masitsa Malenge, Peter P. Ceuppens, Brian J. Middleton, Sebastian Patzke, Trond Stokke

المصدر: Journal of Nuclear Medicine

مصطلحات موضوعية: 0301 basic medicine, Radioimmunoconjugate, medicine.medical_treatment, NHL, Flow cytometry, 03 medical and health sciences, 0302 clinical medicine, rituximab resistance, immune system diseases, hemic and lymphatic diseases, medicine, Radiology, Nuclear Medicine and imaging, Basic, CD20, Antibody-dependent cell-mediated cytotoxicity, medicine.diagnostic_test, biology, business.industry, 177Lu, medicine.disease, Lymphoma, Raji cell, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Radioimmunotherapy, Cancer research, biology.protein, radioimmunotherapy, Rituximab, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5658710a8822c0a7b502104b906a61f9
http://europepmc.org/articles/PMC7539655